Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.

Hemasphere · 2026 · PMC12793093 · PMID 41531664

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendP = 0.1so close (0.05 < p ≤ 0.1)

45 Blasts from responsive patients showed an increase in granulocyte–monocyte progenitor (GMP)‐like gene expression (P = 0.05), whereas refractory blasts showed a trend toward higher hematopoietic stem cell (HSC)‐like scores (P = 0.1) (Figure 3E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.